NCT02955953View on ClinicalTrials.gov

A Study Comparing Two Formulations of Insulin Glargine in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

127

Participants

Timeline

Start Date

November 14, 2016

Primary Completion Date

January 4, 2017

Study Completion Date

January 4, 2017

Conditions

Healthy

Interventions

DRUG

LY2963016

Administered SC

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician., Singapore

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT02955953 - A Study Comparing Two Formulations of Insulin Glargine in Healthy Participants | Biotech Hunter | Biotech Hunter